| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 |
| filingDate |
1997-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a2e945ee6b8b3f71103d7b2c3f5d967
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c03435c261667d1ce3bc3ff206d9f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f919c238c862f074c4e66aab2d39609 |
| publicationDate |
2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6353014-B1 |
| titleOfInvention |
15-ketal postaglandins for the treatment of glaucoma or ocular hypertension |
| abstract |
A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I: |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101137750-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2243771-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I495471-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008033036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8686035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005013928-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012176792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1867310-B |
| priorityDate |
1996-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |